Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation

R.A. Nout; T. Bosse; C.L. Creutzberg; I.M. Jürgenliemk-Schulz; J.J. Jobsen; L.C. Lutgens; E.M. van der Steen-Banasik; R. van Eijk; N.T. ter Haar; V.T. Smit

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation

Translated title of the contribution: Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation

R.A. Nout, T. Bosse, C.L. Creutzberg, I.M. Jürgenliemk-Schulz, J.J. Jobsen, L.C. Lutgens, E.M. van der Steen-Banasik, R. van Eijk, N.T. ter Haar, V.T. Smit

Medical Physics Group

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation
Original language	Undefined/Unknown
Pages (from-to)	466-473
Number of pages	8
Journal	Gynecologic Oncology
Volume	126
Issue number	3
Publication status	Published - 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22609107

Cite this

Nout, R. A., Bosse, T., Creutzberg, C. L., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C., van der Steen-Banasik, E. M., van Eijk, R., ter Haar, N. T., & Smit, V. T. (2012). Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation. Gynecologic Oncology, 126(3), 466-473. http://www.ncbi.nlm.nih.gov/pubmed/22609107

@article{5df75705acf54199822a5fcf26c2b1d8,

title = "Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation",

author = "R.A. Nout and T. Bosse and C.L. Creutzberg and I.M. J{\"u}rgenliemk-Schulz and J.J. Jobsen and L.C. Lutgens and {van der Steen-Banasik}, E.M. and {van Eijk}, R. and {ter Haar}, N.T. and V.T. Smit",

year = "2012",

language = "Undefined/Unknown",

volume = "126",

pages = "466--473",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "3",

}

Nout, RA, Bosse, T, Creutzberg, CL, Jürgenliemk-Schulz, IM, Jobsen, JJ, Lutgens, LC, van der Steen-Banasik, EM, van Eijk, R, ter Haar, NT & Smit, VT 2012, 'Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation', Gynecologic Oncology, vol. 126, no. 3, pp. 466-473. <http://www.ncbi.nlm.nih.gov/pubmed/22609107>

TY - JOUR

T1 - Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation

AU - Nout, R.A.

AU - Bosse, T.

AU - Creutzberg, C.L.

AU - Jürgenliemk-Schulz, I.M.

AU - Jobsen, J.J.

AU - Lutgens, L.C.

AU - van der Steen-Banasik, E.M.

AU - van Eijk, R.

AU - ter Haar, N.T.

AU - Smit, V.T.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0090-8258

VL - 126

SP - 466

EP - 473

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 3

ER -